Skip to main content

Marina Issued Notice of Allowance on Canadian Patent Application for Delivery Tech

Premium

Marina Biotech said this week that the Canadian patent office has issued the company a notice of allowance for a patent application covering amphoteric liposomal formulations and their use for the delivery of nucleic acids and other compounds with therapeutic application.

The application, No. 2,438,116, specifically relates to Marina's Smarticles technology, which it acquired from Novosom last summer (GSN 7/29/2010).

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.